Softgels: Consumer perceptions and market impact relative to other oral dosage forms

Advances in Therapy

Volumn 17, Issue 5, 2000, Pages 213-221

  Jones, William J ^a   Francis, John J ^a  

^a Banner Pharmacaps Inc   (United States)

Author keywords

Consumer; Dosage form; Market impact; Product formulation; Product preference; Softgel

Indexed keywords

BISACODYL; DECONGESTIVE AGENT; EXTRA STRENGTH TYLENOL; IBUPROFEN; PARACETAMOL; PSEUDOEPHEDRINE; SUDAFED NASAL DECONGESTANT; SUDAFED SEVERE COLD; TYLENOL ARTHRITIS; VITAMIN; WAL FINATE ALLERGY DECONGESTANT; WALGREEN'S SINUS FORMULA;

ARTICLE; DRUG DOSAGE FORM; DRUG FORMULATION; GEL; HEALTH SURVEY; PHARMACEUTICAL ENGINEERING; SWALLOWING;

ADMINISTRATION, ORAL; ADULT; AGED; CAPSULES; CONSUMER SATISFACTION; DEGLUTITION; DRUG PACKAGING; FEMALE; HUMANS; MALE; MARKETING OF HEALTH SERVICES; MIDDLE AGED; TABLETS; UNITED STATES;

EID: 0033693590     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02853160     Document Type: Article

References (7)

1. A comparison of the hypnotic effects of temazepam capsules and temazepam elixir
2. Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients
3. Evaluation of two nitroglycerin dosage forms: A metered spray and a soft gelatin capsule
4. Bioavailability and related heart function index of digoxin capsules and tables in cardiac patients
5. Effect of formulation on the bioavailability of retinol, D-alphatocopherol and riboflavine
6. Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers
7. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide